POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW?

Detalles Bibliográficos
Autor principal: Kotha, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475076/
http://dx.doi.org/10.1016/j.ekir.2022.07.081
_version_ 1784789826317320192
author Kotha, C.
author_facet Kotha, C.
author_sort Kotha, C.
collection PubMed
description
format Online
Article
Text
id pubmed-9475076
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-94750762022-09-15 POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW? Kotha, C. Kidney Int Rep Article Published by Elsevier Inc. 2022-09 2022-09-15 /pmc/articles/PMC9475076/ http://dx.doi.org/10.1016/j.ekir.2022.07.081 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kotha, C.
POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW?
title POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW?
title_full POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW?
title_fullStr POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW?
title_full_unstemmed POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW?
title_short POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW?
title_sort pos-064 nephrotoxicity of liposomal amphotericin b in patients with rhino-orbito-cerebral mucormycosis(rocm) in post covid patients -what we need to know?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475076/
http://dx.doi.org/10.1016/j.ekir.2022.07.081
work_keys_str_mv AT kothac pos064nephrotoxicityofliposomalamphotericinbinpatientswithrhinoorbitocerebralmucormycosisrocminpostcovidpatientswhatweneedtoknow

Ejemplares similares